<p>ADCC titers against (<b>A</b>) A/California/07/2009 (H1N1) and (<b>C</b>) A/Hong Kong/156/97 (H5N1) were determined. Titers for mice that survive challenge (open triangles) and mice that succumb to infection (closed triangles) are presented separately for pre-vaccination (pre) and post-vaccination (post) sera. Assay background level is indicated with dashed line in panels A and C. Vaccine homologous H1 ADCC titers are higher in post-vaccination serum (p<0.001, t-test). H5 ADCC titers are detectable in pre-vaccination samples and increase significantly after vaccination (p<0.001, t-test). ROC curves were calculated to assess the correlation (<b>B</b>) between H1N1 ADCC titer and protection against homologous H1N1 challenge (ROC area = 0.7...
<p>A) Timeline for immunization and challenge. B) Influenza H5N1 virus specific serum IgG antibody t...
<p>HI antibody titers were determined against A/Puerto Rico/8/1934 (H1N1) virus and are expressed as...
E animals were challenged with A/Wuhan/95 (H3N2) after receipt of H1N1-immune sera. The best fit lin...
<p>VNA titers against (<b>A</b>) A/California/07/2009 (H1N1) and (<b>C</b>) A/Hong Kong/156/97 (H5N1...
<p>Kaplan-Meier survival curves (left), mean bodyweight change (middle) and median clinical score (r...
<p>Data points represent the mean % of surviving animals 14 days following lethal challenge of CD1 m...
<p>Bars indicate the geometric mean titers±SEM of 6 mice in the H5N1 BPL-WIV vaccination group or th...
<p>Serum samples were collected at 2 weeks after a boosting vaccination. (A) The hemagglutination in...
<p>Sera were collected at 10 days post-last vaccination. PBS was used as the negative control. (A) N...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...
<p>Shown are reciprocal MN titers:</p>a<p>expected titer based on the volume and titer of injected i...
<p>(<b>A</b>) Serum was obtained from 25 human subjects immediately prior to the first vaccination a...
<p>Groups of 7 or 10 CD1 mice received immune sera from (<b>A</b>) CD1 mice, (<b>B</b>) guinea pigs ...
<p>Sera were collected at 10 days post-last vaccination. PBS was used as the negative control. (A) N...
E animals were challenged with A/Wuhan/95 (H3N2) after receipt of H1N1-immune sera. The best fit lin...
<p>A) Timeline for immunization and challenge. B) Influenza H5N1 virus specific serum IgG antibody t...
<p>HI antibody titers were determined against A/Puerto Rico/8/1934 (H1N1) virus and are expressed as...
E animals were challenged with A/Wuhan/95 (H3N2) after receipt of H1N1-immune sera. The best fit lin...
<p>VNA titers against (<b>A</b>) A/California/07/2009 (H1N1) and (<b>C</b>) A/Hong Kong/156/97 (H5N1...
<p>Kaplan-Meier survival curves (left), mean bodyweight change (middle) and median clinical score (r...
<p>Data points represent the mean % of surviving animals 14 days following lethal challenge of CD1 m...
<p>Bars indicate the geometric mean titers±SEM of 6 mice in the H5N1 BPL-WIV vaccination group or th...
<p>Serum samples were collected at 2 weeks after a boosting vaccination. (A) The hemagglutination in...
<p>Sera were collected at 10 days post-last vaccination. PBS was used as the negative control. (A) N...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...
<p>Shown are reciprocal MN titers:</p>a<p>expected titer based on the volume and titer of injected i...
<p>(<b>A</b>) Serum was obtained from 25 human subjects immediately prior to the first vaccination a...
<p>Groups of 7 or 10 CD1 mice received immune sera from (<b>A</b>) CD1 mice, (<b>B</b>) guinea pigs ...
<p>Sera were collected at 10 days post-last vaccination. PBS was used as the negative control. (A) N...
E animals were challenged with A/Wuhan/95 (H3N2) after receipt of H1N1-immune sera. The best fit lin...
<p>A) Timeline for immunization and challenge. B) Influenza H5N1 virus specific serum IgG antibody t...
<p>HI antibody titers were determined against A/Puerto Rico/8/1934 (H1N1) virus and are expressed as...
E animals were challenged with A/Wuhan/95 (H3N2) after receipt of H1N1-immune sera. The best fit lin...